Amphastar Pharmaceuticals (AMPH) Interest Coverage Ratio (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Interest Coverage Ratio of 1.87 for Q1 2026, down 62.01% year-over-year from 4.92 in Q1 2025, and down 65.21% quarter-over-quarter from 5.37 in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 1.87 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 62.01% year-over-year to 1.87; the TTM figure through Mar 2026 stood at 4.78 (down 14.04% YoY), while the FY2025 annual figure was 0.34, down 84.04% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 1.87, down from 5.37 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 36.02 in Q1 2022, with the low at 0.08 in Q2 2023.
- The 5-year median for Interest Coverage Ratio is 2.11 (2025), against an average of 6.69.
- Peak annual rise in Interest Coverage Ratio reached 500.49% in 2024, while the deepest fall reached 79.29% in 2024.
- Amphastar Pharmaceuticals' Interest Coverage Ratio stood at 9.76 in 2022, then sank by 65.16% to 3.4 in 2023, then jumped by 358.86% to 15.6 in 2024, then sank by 65.58% to 5.37 in 2025, then slumped by 65.21% to 1.87 in 2026.
- Business Quant data shows AMPH's Interest Coverage Ratio at 1.87 in Q1 2026, 5.37 in Q4 2025, and 0.76 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 936.60 Mn | 646.48 Mn | 93.47 Mn | 5.97 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.51 |
| Mar 31, 2026 | 1.87 |
| Dec 31, 2025 | 5.37 |
| Sep 30, 2025 | 0.76 |
| Jun 30, 2025 | 2.11 |
| Mar 31, 2025 | 4.92 |
| Dec 31, 2024 | 15.60 |
| Sep 30, 2024 | 0.34 |
| Jun 30, 2024 | 0.46 |
| Mar 31, 2024 | 5.56 |
| Dec 31, 2023 | 3.40 |
| Sep 30, 2023 | 0.15 |
| Jun 30, 2023 | 0.08 |
| Mar 31, 2023 | 26.85 |
| Dec 31, 2022 | 9.76 |
| Sep 30, 2022 | 0.26 |
| Jun 30, 2022 | 0.18 |
| Mar 31, 2022 | 36.02 |
| Dec 31, 2021 | 18.90 |
| Sep 30, 2021 | 0.74 |